Abstract:Epidemiological and clinical studies have found associations between depression and cardiovascular disease risk factors, and coronary artery disease patients with depression have worse prognosis. The genetic relationship between depression and these cardiovascular phenotypes is not known. We here investigated overlap at the genome-wide level and in individual loci between depression, coronary artery disease and cardiovascular risk factors. We used the bivariate causal mixture model (MiXeR) to quantify genome-wide polygenic overlap and the conditional/conjunctional false discovery rate (pleioFDR) method to identify shared loci, based on genome-wide association study summary statistics on depression (n = 450,619), coronary artery disease (n = 502,713) and nine cardiovascular risk factors (n = 204,402–776,078). Genetic loci were functionally annotated using FUnctional Mapping and Annotation (FUMA). Of 13.9K variants influencing depression, 9.5K (SD 1.0K) were shared with body-mass index. Of 4.4K variants influencing systolic blood pressure, 2K were shared with depression. ConjFDR identified 79 unique loci associated with depression and coronary artery disease or cardiovascular risk factors. Six genomic loci were associated jointly with depression and coronary artery disease, 69 with blood pressure, 49 with lipids, 9 with type 2 diabetes and 8 with c-reactive protein at conjFDR < 0.05. Loci associated with increased risk for depression were also associated with increased risk of coronary artery disease and higher total cholesterol, low-density lipoprotein and c-reactive protein levels, while there was a mixed pattern of effect direction for the other risk factors. Functional analyses of the shared loci implicated metabolism of alpha-linolenic acid pathway for type 2 diabetes. Our results showed polygenic overlap between depression, coronary artery disease and several cardiovascular risk factors and suggest molecular mechanisms underlying the association between depression and increased cardiovascular disease risk. Studies have found associations between depression and both cardiovascular disease risk factors and worse cardiovascular disease prognosis. It is unknown if shared genetic factors contribute to these associations. We applied novel statistical tools for polygenic architectures to investigate if there are common genes for depression, coronary artery disease and cardiovascular risk factors (body mass index, blood pressure, lipids, type 2 diabetes and c-reactive protein). We used the statistical methods the bivariate causal mixture model (MiXeR) and the conditional/conjunctional false discovery rate (pleioFDR) to quantify genome-wide overlap and to identify shared genetic variants. We found extensive genetic overlap. Depression shared 68% of genetic variants with body mass index and 14% and with systolic blood pressure. We also identified 79 unique genomic variants associated with depression and coronary artery disease or the risk factors. Variants associated with increased risk for depression also increased the risk of coronary artery disease, some of the lipids and c-reactive protein levels, while there was a mixed pattern of direction for the other risk factors. Further analyses identified shared genetic variants found in metabolism of alpha-linolenic pathway for type 2 diabetes.

Local patterns of genetic sharing challenge the boundaries between neuropsychiatric and insulin resistance-related conditions

The multivariate genetic architecture of psychiatric and insulin resistance multimorbidity

Unravelling the joint genetic architecture between psychiatric and insulin-related traits in the general population

Statistical examination of shared loci in neuropsychiatric diseases using genome-wide association study summary statistics

Integrative analyses highlight functional regulatory variants associated with neuropsychiatric diseases

Identification of novel genomic risk loci shared between common epilepsies and psychiatric disorders

Genome wide meta-analysis identifies genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders

Investigating the common genetic architecture and causality of metabolic disorders with neurodegenerative diseases

Evidence for Shared Genetic Aetiology Between Schizophrenia, Cardiometabolic, and Inflammation-Related Traits: Genetic Correlation and Colocalization Analyses

Shared genetic loci between depression and cardiometabolic traits

Divergent patterns of genetic overlap between severe mental disorders and metabolic markers

Integrative Analysis of Genome-Wide Association Studies Identifies Novel Loci Associated with Neuropsychiatric Disorders

Identification of novel genomic loci for anxiety symptoms and extensive genetic overlap with psychiatric disorders

Shared mechanisms across the major psychiatric and neurodegenerative diseases

Exploring Lead loci shared between schizophrenia and Cardiometabolic traits

Co-localization of Conditional eQTL and GWAS Signatures in Schizophrenia

Dissecting shared genetic architecture between obesity and multiple sclerosis

Identification of shared genetic susceptibility locus for coronary artery disease, type 2 diabetes and obesity: a meta-analysis of genome-wide studies

Biological Insights from Schizophrenia-associated Loci in Ancestral Populations

Synergistic effects of common schizophrenia risk variants

Quantifying the relative importance of genetics and environment on the comorbidity between mental and cardiometabolic disorders using 17 million Scandinavians